CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Phase II Study of Tipifarnib in Advanced Non-Hematological Malignancies With HRAS Mutations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02383927
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:23.027754+00:00
Published At: 2024-07-11T00:00:00+00:00
Record Updated At: 2024-07-11
Results Posted At: 2024-07-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Thyroid Cancer", "Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)", "HRAS Mutant Tumor", "Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-11"
protocolSection.identificationModule.nctId: "NCT02383927"
protocolSection.identificationModule.officialTitle: "An Open Label Phase II Study of Tipifarnib in Advanced Non-Hematological Malignancies With HRAS Mutations"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-07-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.